Revivocell is a UK spin-out from Lancaster University based at Sci-Tech Daresbury Science Incubator Hub, Warrington. We develop cell culture technology to improve life sciences research and enhance drug discovery success. We want to enable scientists to be more creative in their research by proving next dimension cell culture technology, which is easy to use and interactive, whilst closely mimicking body-like conditions and reduces animal testing.
Get to know the faces behind the innovation
Dr. Valon Llabjani (Founder and CEO)
He has a PhD in Biomedical Science and 15 years of life sciences research with commercial experience, successfully managing a number of academic and commercial projects. At Revivocell he lead CELLBLOKS innovations and built a team that led to number of patent applications and raised funding to support business development. He has experience in the inter-disciplinary fields of product design; 3-D cell culture, toxicology, polymer chemistry, cancer biology and analytical chemistry, and has published >20 academic peer reviewed journals.
Dr. Valmira Hoti (Chief Operations Officer)
Dr. Valmira Hoti is responsible for devising commercialisation strategies and operations. With a BSc (hons) in Banking & Finance, a PhD in Statistics (Lancaster) she also has worked in a bank's business growth sector assisting innovative tech start-ups with finance and commercialisation
Dr. Afaf Abozoid (Postdoctoral Scientists)
Dr Abozoid has BSc in Pharmacy and Pharmaceutical Science at University of Alexandria, Egypt, an MSc Analytical Bioscience and Drug Design (University of Salford, UK). She has completed her PhD in the PhD Pharmaceutical Sciences, University of Central Lancashire, UK. Afaf has extensive experience in fields of drug development and screening, separation science, drug delivery, nano-technology formulations, physicochemical characterisation of nanoparticles, cell culture techniques, fluorescent microscopy and macrophage differentiation and polarisation
Prof. Francis L Martin
Prof Martin’s group at University of Central Lancashire has an exemplary and world-leading record in the area of toxicology over many years. His laboratory specializes in the application of a range of toxicology tests, including the alkaline comet assay and the cytokinesis- block micronucleus assay. Prof Martin is current President of the UK Environmental Mutagen Society and Officer on the committee of its European counterpart, which has a significant industry component. He is also an Expert Member of the DoH Committee on Mutagenicity and on the OECD panel for developing a regulatory guideline for transformation assays.
Dr. Imran Patel (Advisory Board)
Dr. Imran Patel has a PhD in Biological Sciences (Lancaster University), postdoctoral fellow training at the University of Cambridge, King Abdullah University of Science and Technology and an honorary postdoctoral fellow at Imperial College London NHS trust. He has extensive experience in application of vibrational spectroscopy for bio-sensing and bio-imaging of cancer, with particular emphasis on clinical translation.
Dr. Ahtasham Raza (Advisory Board)
Dr Ahtasham Raza has an interdisciplinary BBSRC funded PhD from The University of Sheffield and had a 3-year post-doctorate research associate position at The Kroto Research Insititute (The University Of Sheffield, UK). His research involved the development of 3D soft tissue engineering and bioimaging. In particular, the development of 2D/3D cell culture from primary and iPSC cell culture for development of normal and diseased model, including skin modelling, oncology, for drug discovery and toxicology testing